Bel Air Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$714K Sell
6,335
-6,823
-52% -$768K 0.02% 217
2021
Q1
$1.42M Buy
+13,158
New +$1.41M 0.04% 160
2013
Q3
$720K Buy
16,093
+12
+0.1% +$532 0.1% 68
2013
Q2
$665K Buy
+16,081
New +$703K 0.1% 68

Other funds holding ABBV

Bel Air Investment Advisors's ABBV Position: Q2 2021 in Review

Bel Air Investment Advisors reduced its AbbVie (ABBV) stake by 52% in Q2 2021, selling an estimated $768K and leaving 6,335 shares worth $714K. The position accounts for 0.02% of the portfolio, ranked #217.

Bel Air Investment Advisors first reported a position in ABBV in Q2 2013 and has held it in 4 quarters since. The position peaked at $1.42M in Q1 2021. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

  • Bel Air Investment Advisors held 6,335 shares of AbbVie worth $714K as of Q2 2021.
  • Bel Air Investment Advisors sold 6,823 AbbVie shares in Q2 2021, an estimated $768K.
  • AbbVie made up 0.02% of Bel Air Investment Advisors's portfolio in Q2 2021, its #217 holding.
  • Bel Air Investment Advisors first reported a position in AbbVie in Q2 2013 and has held it in 4 quarters since.
  • Bel Air Investment Advisors's AbbVie position peaked at $1.42M in Q1 2021.
  • 2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Bel Air Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.